Xylem (XYL) EBT (2010 - 2026)

Xylem's EBT history runs 17 years deep, the most recent figure standing at $244.0 million for Q1 2026.

• In Q1 2026, EBT rose 12.44% year-over-year to $244.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 9.03% YoY), while the FY2025 annual figure was $1.2 billion, up 8.65% from the prior year.
• EBT was $244.0 million for Q1 2026 at Xylem, down from $368.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $375.0 million in Q4 2024 to a low of $17.0 million in Q3 2022.
• Historically, EBT has averaged $211.0 million across 5 years, with a median of $210.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT slumped 87.22% in 2022, then surged 988.24% in 2023.
• A 5-year view of EBT shows it stood at $189.0 million in 2022, then gained by 11.11% to $210.0 million in 2023, then jumped by 78.57% to $375.0 million in 2024, then slipped by 1.87% to $368.0 million in 2025, then slumped by 33.7% to $244.0 million in 2026.
• The last three EBT figures came in at $244.0 million (Q1 2026), $368.0 million (Q4 2025), and $297.0 million (Q3 2025), per Business Quant data.